Regency Capital Management Inc.\De Aura Biosciences, Inc. Transaction History
Regency Capital Management Inc.\De
- $188 Million
- Q2 2025
A detailed history of Regency Capital Management Inc.\De transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Regency Capital Management Inc.\De holds 665,881 shares of AURA stock, worth $4.62 Million. This represents 2.21% of its overall portfolio holdings.
Number of Shares
665,881
Previous 749,482
11.15%
Holding current value
$4.62 Million
Previous $4.39 Million
5.08%
% of portfolio
2.21%
Previous 2.68%
Shares
13 transactions
Others Institutions Holding AURA
# of Institutions
105Shares Held
51.5MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$48 Million22.54% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$35.4 Million1.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$33.9 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$32.1 Million1.33% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$30.3 Million0.94% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $203M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...